Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07810439) titled 'PROTECT-Africa: Biomarker Validation for Preeclampsia Triage' on Sept. 3.
Study Type: Observational [Patient Registry]
Primary Sponsor: Africa Clinical Research Network (ACRN)
Condition:
Hypertension, Pregnancy-Induced
HELLP Syndrome
Eclampsia
Fetal Growth Retardation
Pre-eclampsia
Recruitment Status: Recruiting
Date of First Enrollment: February 5, 2026
Target Sample Size: 1106
Countries of Recruitment:
Zimbabwe
To know more, visit https://clinicaltrials.gov/study/NCT07810439
Disclaimer: Curated by HT Syndication....